ketoconazole has been researched along with tretinoin in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (10.20) | 18.7374 |
1990's | 17 (34.69) | 18.2507 |
2000's | 14 (28.57) | 29.6817 |
2010's | 13 (26.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Brodie, AM; Clement, OO; Gediya, LK; Goloubeva, OG; Handratta, VD; Huynh, CK; Nanne, IP; Njar, VC; Patel, JB; Soprano, DR | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Aström, A; Chambon, P; Duell, EA; Griffiths, CE; Voorhees, JJ | 1 |
Boerman, MH; Burns, RD; Napoli, JL; Posch, KC | 1 |
Coene, MC; Cools, W; Goossens, J; Monbaliu, J; Van Wauwe, JP | 1 |
Janssen, PA; Vanden Bossche, H; Willemsens, G | 1 |
Coene, MC; Cools, W; Goossens, J; Lauwers, W; Van Nijen, G; Van Wauwe, JP | 1 |
Hay, RJ | 1 |
Napoli, JL; Williams, JB | 1 |
Napoli, JL | 1 |
Calayag, M; Fossella, FV; Hong, WK; Krakoff, IH; Lee, JS; Lippman, SM; Newman, RA; Raber, MN | 1 |
Muindi, JR; Warrell, RP; Young, CW | 2 |
Adamson, PC | 1 |
Buzney, SM; Dowgiert, RK; Doyle, JW | 1 |
Fiorella, PD; Napoli, JL | 1 |
DeGrazia, F; Francis, PA; Huselton, C; Kris, MG; Muindi, JR; Orazem, JP; Rigas, JR; Warrell, RP; Young, CW | 1 |
Bruynseels, J; De Coster, R; Wouters, W | 1 |
Duell, EA; Kang, S; Li, XY; Voorhees, JJ | 1 |
Randolph, RK; Simon, M | 1 |
Dräger, UC; McCaffery, P; Yamamoto, M | 1 |
Byun, Y; Carey, TE; Choi, JH; Chung, JW; Han, IS; Kim, SH; Kim, SY; Lee, HR; Lee, KS; Yu, HK | 1 |
Maden, M; Sonneveld, E; van den Brink, CE; van der Leede, BJ; van der Saag, PT | 1 |
Chithalen, JV; Jones, G; Luu, L; Petkovich, M | 1 |
Ahmadi, M; Le Baut, G; Le Borgne, M; Marchand, P; Nicholls, PJ; Smith, HJ | 1 |
Araico, A; Cárcel-Trullols, J; Peris, JE; Saadeddin, A; Torres-Molina, F | 1 |
Angotti, M; Hartmann, RW; Kirby, AJ; Nicholls, PJ; Sewell, RD; Simons, C; Smith, HJ | 1 |
Arzt, E; Castillo, V; Giacomini, D; Grossman, AB; Holsboer, F; Labeur, M; Páez-Pereda, M; Stalla, GK; Stalla, J; Theodoropoulou, M | 1 |
Jacobson, EL; Jacobson, MK; Kim, H; Tashtoush, BM | 1 |
el-Metwally, TH; Hameed, DA | 1 |
Lotan, R; Lotan, Y | 1 |
Avram, MR; Rogers, NE | 1 |
Maares, J; Meyer, I; Roos, B; Sauer, J; Schmitt-Hoffmann, AH; Schoetzau, A; Spickermann, J | 1 |
Buttrick, B; Goodlett, DR; Isoherranen, N; Nelson, WL; Shaffer, SA; Shimshoni, JA; Thatcher, JE | 1 |
Barahona Constanzo, MJ; del Pozo Picó, C | 1 |
Blackburn, J; Blom, A; Ishizawa, M; Lancaster, ST; Makishima, M; Mansell, JP | 1 |
6 review(s) available for ketoconazole and tretinoin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemia.
Topics: Animals; Clinical Trials as Topic; Drug Administration Schedule; Humans; Ketoconazole; Leukemia, Promyelocytic, Acute; Macaca mulatta; Time Factors; Tretinoin | 1994 |
Clinical pharmacology of all-trans retinoic acid.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Ketoconazole; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Male; Metabolic Clearance Rate; Multiple Myeloma; Oxidation-Reduction; Prostatic Neoplasms; Tretinoin | 1994 |
P450-dependent enzymes as targets for prostate cancer therapy.
Topics: Adenocarcinoma; Aldehyde-Lyases; Androgen Antagonists; Androgens; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Cattle; Clinical Trials as Topic; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Humans; Imidazoles; Ketoconazole; Male; Mice; Neoplasm Proteins; Prostatic Neoplasms; Rats; Rats, Wistar; Salvage Therapy; Steroid 17-alpha-Hydroxylase; Tretinoin; Tumor Cells, Cultured | 1996 |
Medical treatments for male and female pattern hair loss.
Topics: Adult; Alopecia; Androgen Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Female; Finasteride; Hair; Humans; Hyperhidrosis; Ketoconazole; Male; Minoxidil; Phototherapy; Prostate; Sperm Count; Tretinoin | 2008 |
New prospects for drug treatment in Cushing disease.
Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Cabergoline; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Ergolines; Etomidate; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Metyrapone; Mice; Mifepristone; Mitotane; Multicenter Studies as Topic; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; PPAR gamma; Pyridines; Rats; Somatostatin; Therapies, Investigational; Tretinoin | 2012 |
5 trial(s) available for ketoconazole and tretinoin
Article | Year |
---|---|
Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors.
Topics: Adult; Aged; Female; Humans; Ketoconazole; Male; Middle Aged; Neoplasms; Tretinoin | 1995 |
Clinical pharmacology of all-trans retinoic acid.
Topics: Antineoplastic Agents; Drug Administration Schedule; Half-Life; Humans; Ketoconazole; Neoplasms; Stereoisomerism; Tretinoin | 1994 |
Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole.
Topics: Carcinoma, Non-Small-Cell Lung; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Humans; Ketoconazole; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Neoplasms; Tretinoin | 1993 |
Retinoic acid as a novel medical therapy for Cushing's disease in dogs.
Topics: Adenoma; Adrenocorticotropic Hormone; alpha-MSH; Animals; Body Weight; Creatinine; Dog Diseases; Dogs; Female; Hydrocortisone; Ketoconazole; Magnetic Resonance Imaging; Male; Pituitary ACTH Hypersecretion; Pituitary Gland; Pituitary Neoplasms; Survival Rate; Tretinoin | 2006 |
Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A.
Topics: Adolescent; Adult; Alitretinoin; Antifungal Agents; Cross-Over Studies; Cyclosporine; Dermatologic Agents; Drug Administration Schedule; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Ketoconazole; Male; Middle Aged; Simvastatin; Tretinoin; Young Adult | 2011 |
38 other study(ies) available for ketoconazole and tretinoin
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cricetinae; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; Humans; Male; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Microsomes, Liver; Neoplasm Transplantation; Prostatic Neoplasms; Retinoic Acid 4-Hydroxylase; Stereoisomerism; Transplantation, Heterologous; Tretinoin | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Overcoming drug resistance: studies presented at ASCO.
Topics: Antigens, CD; Antigens, CD34; Cyclosporine; Drug Resistance; Humans; Ketoconazole; Leukemia; Tretinoin | 1992 |
Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro.
Topics: Administration, Topical; Adult; Carrier Proteins; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Ketoconazole; Receptors, Retinoic Acid; Skin; Transcription, Genetic; Tretinoin | 1992 |
Holocellular retinol binding protein as a substrate for microsomal retinal synthesis.
Topics: Animals; Ethanol; Ketoconazole; Kinetics; Male; Microsomes; Microsomes, Liver; NADP; Organ Specificity; Rats; Rats, Inbred Strains; Retinaldehyde; Retinol-Binding Proteins; Retinol-Binding Proteins, Cellular; Tretinoin | 1991 |
Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats.
Topics: Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Imidazoles; Ketoconazole; Male; Rats; Rats, Inbred Strains; Tretinoin | 1990 |
Cytochrome-P-450-dependent metabolism of retinoic acid in rat skin microsomes: inhibition by ketoconazole.
Topics: Animals; Animals, Newborn; Antimetabolites; Biotransformation; Carbon Monoxide; Cricetinae; Cytochrome P-450 Enzyme System; In Vitro Techniques; Itraconazole; Ketoconazole; Mesocricetus; Miconazole; Microsomes; Microsomes, Liver; Oxygen; Rats; Rats, Inbred Strains; Skin; Tretinoin | 1988 |
Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid.
Topics: Animals; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Cricetinae; Female; Gas Chromatography-Mass Spectrometry; Ketoconazole; Kinetics; Liver; Male; Mesocricetus; Microsomes, Liver; Rats; Rats, Inbred Strains; Tretinoin | 1988 |
The current status of antimycotics in the treatment of local mycoses.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Benzoates; Dermatomycoses; Drug Combinations; Etretinate; Female; Griseofulvin; Humans; Imidazoles; Ketoconazole; Nystatin; Potassium Permanganate; Resorcinols; Salicylates; Salicylic Acid; Suppositories; Tretinoin; Vagina | 1986 |
Inhibition of retinoic acid metabolism by imidazole antimycotics in F9 embryonal carcinoma cells.
Topics: Cell Line; Clotrimazole; Embryonal Carcinoma Stem Cells; Imidazoles; Ketoconazole; Metyrapone; Miconazole; Neoplastic Stem Cells; Tretinoin | 1987 |
Retinol metabolism in LLC-PK1 Cells. Characterization of retinoic acid synthesis by an established mammalian cell line.
Topics: Animals; Cell Line; Disulfiram; Half-Life; Ketoconazole; Kidney; Kinetics; Swine; Tretinoin; Vitamin A | 1986 |
Retinoic acid metabolism in cultured retinal pigment epithelial cells.
Topics: Animals; Cattle; Cell Division; Cells, Cultured; Chromatography, Thin Layer; Cytochrome P-450 Enzyme System; Ketoconazole; Oxygenases; Pigment Epithelium of Eye; Subcellular Fractions; Tretinoin | 1995 |
Microsomal retinoic acid metabolism. Effects of cellular retinoic acid-binding protein (type I) and C18-hydroxylation as an initial step.
Topics: Animals; Hydroxylation; Ketoconazole; Kidney; Liver; Lung; Male; Microsomes; Rats; Receptors, Retinoic Acid; Testis; Tretinoin | 1994 |
The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo.
Topics: Adult; Alitretinoin; Calcitriol; Cytochrome P-450 Enzyme System; Drug Synergism; Gene Expression; Humans; Ketoconazole; Receptors, Retinoic Acid; Retinoid X Receptors; Skin; Steroid Hydroxylases; Transcription Factors; Transcription, Genetic; Tretinoin; Vitamin D3 24-Hydroxylase | 1997 |
Metabolism of all-trans-retinoic acid by cultured human epidermal keratinocytes.
Topics: Albumins; Cells, Cultured; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Epidermis; Esters; Homeostasis; Humans; Keratinocytes; Ketoconazole; Kinetics; Tretinoin | 1997 |
A novel assay for retinoic acid catabolic enzymes shows high expression in the developing hindbrain.
Topics: Aging; Animals; Animals, Newborn; Embryo, Mammalian; Embryonic and Fetal Development; Enzymes; Ketoconazole; Methods; Mice; NADP; Receptors, Retinoic Acid; Recombinant Proteins; Rhombencephalon; Tretinoin | 1998 |
The induction of P450-mediated oxidation of all-trans retinoic acid by retinoids in head and neck squamous cell carcinoma cell lines.
Topics: Antibiotics, Antineoplastic; Antifungal Agents; Antineoplastic Agents; Carcinoma, Squamous Cell; Cycloheximide; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dactinomycin; Enzyme Induction; Head and Neck Neoplasms; Humans; Ketoconazole; Oxidation-Reduction; Protein Synthesis Inhibitors; Retinoids; Tretinoin; Tumor Cells, Cultured | 1998 |
Embryonal carcinoma cell lines stably transfected with mRARbeta2-lacZ: sensitive system for measuring levels of active retinoids.
Topics: Animals; Carcinoma, Embryonal; Chick Embryo; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Gene Expression Regulation, Developmental; Genes, Reporter; Imidazoles; Isomerism; Ketoconazole; Limb Buds; Mesoderm; Mice; Promoter Regions, Genetic; Receptors, Retinoic Acid; Retinoids; Time Factors; Transcriptional Activation; Transfection; Tretinoin; Tumor Cells, Cultured | 1999 |
HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A.
Topics: Animals; Chromatography, High Pressure Liquid; Cricetinae; Cricetulus; Cytochrome P-450 Enzyme System; HeLa Cells; Humans; Ketoconazole; Mass Spectrometry; Recombinant Proteins; Retinoic Acid 4-Hydroxylase; RNA, Messenger; Tretinoin | 2002 |
Retinoic acid metabolism inhibition by 3-azolylmethyl-1H-indoles and 2, 3 or 5-(alpha-azolylbenzyl)-1H-indoles.
Topics: Animals; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Hydroxylation; In Vitro Techniques; Indoles; Ketoconazole; Microsomes, Liver; Molecular Structure; Rats; Structure-Activity Relationship; Tretinoin; Triazoles | 2003 |
Effect of cytochrome P450 inhibitors (diethyl dithiocarbamate, ketoconazole and grapefruit juice) on the pharmacokinetics of all-trans-retinoic acid.
Topics: Animals; Beverages; Citrus paradisi; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Ditiocarb; Enzyme Inhibitors; Ketoconazole; Rats; Tretinoin | 2004 |
Effect of 2-(4-aminophenylmethyl)-6-hydroxy-3, 4-dihydronaphthalen-1(2H)-one on all-trans and 13-cis-retinoic acid levels in plasma quantified by high perfomance liquid chromatography coupled to tandem mass spectrometry.
Topics: Animals; Chromatography, High Pressure Liquid; Isotretinoin; Ketoconazole; Male; Mass Spectrometry; Naphthalenes; Rats; Rats, Inbred WF; Spectrometry, Mass, Electrospray Ionization; Tetralones; Tretinoin | 2005 |
Formulation compatibility of myristyl nicotinate with drugs used to treat dermatological conditions involving an impaired skin barrier.
Topics: Chemistry, Pharmaceutical; Dermatologic Agents; Humans; Hydrocortisone; Ketoconazole; Metronidazole; Niacin; Skin; Skin Diseases; Tretinoin; Triamcinolone Acetonide | 2007 |
The effectiveness of retinoic acid treatment in bladder cancer: impact on recurrence, survival and TGFalpha and VEGF as end-point biomarkers.
Topics: Aged; Biomarkers; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Humans; Ketoconazole; Middle Aged; Neoplasm Recurrence, Local; Transforming Growth Factor alpha; Tretinoin; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A | 2008 |
Prevention of bladder cancer recurrence by retinoic acid-ketoconazole: a promising strategy?
Topics: Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Drug Therapy, Combination; Humans; Ketoconazole; Neoplasm Recurrence, Local; Tretinoin; Urinary Bladder Neoplasms | 2008 |
Substrate specificity and ligand interactions of CYP26A1, the human liver retinoic acid hydroxylase.
Topics: Animals; Cell Line; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Ketoconazole; Ligands; Liver; Mixed Function Oxygenases; Protease Inhibitors; Rats; Retinoic Acid 4-Hydroxylase; Substrate Specificity; Tretinoin | 2011 |
24,25-Dihydroxyvitamin D3 cooperates with a stable, fluoromethylene LPA receptor agonist to secure human (MG63) osteoblast maturation.
Topics: 24,25-Dihydroxyvitamin D 3; 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Calcitriol; Cell Differentiation; Fluorescent Dyes; Humans; Ketoconazole; Mitogens; Organophosphonates; Osteoblasts; Osteocalcin; Receptors, Calcitriol; Receptors, Lysophosphatidic Acid; Stereoisomerism; Transcription, Genetic; Tretinoin | 2014 |